Device Trial Radar · NCT04252352
Treatment of Acne Scars With Fractional CO2 Laser Versus Radio-frequency Microneedling
Last checked: Nov 19, 2026Latest source record: Feb 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
15
Planned (sponsor's estimate)
Start
Feb 2020
Primary completion
Oct 2020
Study completion Oct 2020
Sponsor
- Lead sponsor
- Aarhus University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Bispebjerg Hospital
- First posted
- Feb 5, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study is a prospective, randomized, controlled, intra-person split-face trial with blinded evaluations. The objective is to compare efficacy and adverse effects of ablative fractional CO2 laser resurfacing versus radio-frequency microneedling for treatment of atrophic acne scars in the facial area. Two comparable areas with acne scars on each side of the face are treated. One area will be treated with fractional CO2 laser and the other area with radio-frequency microneedling. Outcome measures will be assessed by blinded investigators and included subjects at baseline before treatment and at follow-up visits 2-4 days and 1 and 3 months post-treatment. On-site assessment and OCT will be performed at the time of the visits. OCT scans will be offered to the subjects and are optional. Clinical photos are used for documentation. 15 participants will be recruited. The participants will be recruited to enter the trial in the clinic by investigators at the Department of Dermatology, Bispebjerg Hospital, and must meet the inclusion criteria (at least 18 years of age, acne scars in the facial area, comparable atrophic acne scars on each side of the face, fitzpatrick skintype I-III) to be eligible to enter the study. No personal remuneration will be awarded the investigators. None of the collaborators have any personal economic interest in the study. Participants will not receive remuneration. All treatments are performed at the Department of Bispebjerg Hospital and patients are covered by the Hospital's patient insurance. The declaration of Helsinki will be respected as well as the standards of good clinical research. Respect for privacy as well as physically and mentally integrity of the participants will be maintained. The study will be performed in accordance with Danish Health care authorities.
Conditions
- Acne Scars - Mixed Atrophic and Hypertrophic
Interventions
Ablative fractional CO2 laser resurfacing/Radio-frequency microneedlingDevice
Intra-person split-face trial
Primary outcomes
What the sponsor says the trial is designed to measure.
- Asymmetry (scar texture, erythema, pigmentation)Time frame: 3 months
- Patient satisfactionTime frame: 3 months
- Adverse effects ( wounds, scars, pigmentation, erythema, edema)Time frame: 3 months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.